ArticleScientific reports2025
Design and optimization of localized plasmon resonance sensing via square-slotted Ag-graphene-dielectric metasurfaces for dermatological cancer identification using machine learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer is a dangerous, life-threatening illness impacting countless individuals globally, requiring urgent awareness, prevention, and early detection. It is one of the most common forms of cancer, often caused by excessive sun exposure or tanning, and requires early detection for effective treatment. Early detection of skin cancer is achievable through advanced sensor designs that utilize graphene material. Graphene's exceptional properties make it extremely appropriate for creating sensitive, accurate, and non-invasive diagnostic tools to identify cancer at early stages. The integration of silver (Ag), graphene, and silicon dioxide (SiO₂) materials forms a highly sensitive multilayer structure, significantly enhancing the surface plasmon resonance response, which enables precise detection of skin cancer biomarkers at extremely low concentrations. An exceptional sensitivity of 1050 nm/RIU is attained, enabling efficient skin cancer detection through advanced plasmonic biosensing technology. Optimizing the biosensor design by systematically varying key physical parameters-such as layer thicknesses, slot dimensions, and material configurations-significantly enhanced its sensitivity. The optimization is also achieved by using a Machine learning algorithm. The highest R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.